Postnatal muscle modification by myogenic factors modulates neuropathology and survival in an ALS mouse model

Nature Communications

Volumn 4, Issue , 2013, Pages

  Park, Kevin H J ^a   Franciosi, Sonia ^a   Leavitt, Blair R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MYOGENIC FACTOR; MYOGENIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SUCCINATE DEHYDROGENASE; MYOD PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE TRANSFER; MALE; MOTONEURON; MOTOR PERFORMANCE; MOUSE; MUSCLE; MUSCLE DENERVATION; MUSCLE INNERVATION; NERVE CELL DEGENERATION; NERVE ENDING; NEUROPATHOLOGY; NONHUMAN; PERINATAL PERIOD; SPINAL CORD; STAINING; AGE; ANIMAL; DISEASE COURSE; DISEASE MODEL; GENETICS; INNERVATION; METABOLISM; MUTANT MOUSE STRAIN; PATHOLOGY; PATHOPHYSIOLOGY; ROTAROD TEST; SKELETAL MUSCLE; TRANSGENIC MOUSE;

MUS;

AGE FACTORS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENE TRANSFER TECHNIQUES; MALE; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MOTOR NEURONS; MUSCLE, SKELETAL; MYOD PROTEIN; MYOGENIN; ROTAROD PERFORMANCE TEST; SPINAL CORD;

MLCS; MLOWN;

EID: 84903870465     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3906     Document Type: Article

References (60)

1. Dengler, R. et al. Amyotrophic lateral sclerosis: macro-EMG and twitch forces of single motor units. Muscle Nerve 13, 545-550 (1990).
2. Sanjak, M. et al. Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis. J. Neurol. Sci. 191, 55-59 (2001).
3. Atkin, J. D. et al. Properties of slow- and fast-twitch muscle fibres in a mouse model of amyotrophic lateral sclerosis. Neuromuscul. Disord. 15, 377-388 (2005).
4. Gordon, T., Putman, C. T. & Hegedus, J. Amyotrophic lateral sclerosis - evidence of early denervation of fast-twitch muscles. Basic Appl. Myol. 17, 141-145 (2007).
5. Wong, M. & Martin, L. J. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 19 2284-2302 (2010).
6. G93A mediated toxicity. Cell Metab. 8, 425-436 (2008).
7. Miller, T. M. et al. Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 103, 19546-19551 (2006).
8. Dobrowolny, G. et al. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J. Cell Biol. 168, 193-199 (2005).
9. Megeney, L. & Rudnicki, M. A. Determination versus differentation and the MyoD family of transcription factors. Biochem. Cell Biol. 73, 723-732 (1995).
10. Perry, R. L. & Rudnicki, M. A. Molecular mechanisms regulating myogenic determination and differentiation. Front. Biosci. 5, D570-D767 (2000).
11. Hughes, S. M. et al. Selective accumulation of myoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones. Development 118, 1137-1147 (1993).
12. Maves, L. et al. Pbx homeodomain proteins direct MyoD activity to promote fast-muscle differentiation. Development 134, 3371-3382 (2007).
13. Ekmark, M., Rana, Z. A., Stewart, G., Hardie, D. G. & Gundersen, K. De-phosphorylation of MyoD is linking nerve-evoked activity to fast myosin heavy chain expression in rodent adult skeletal muscle. J. Physiol. 584, 637-650 (2007).
14. Hughes, S. M., Chi, M. M.-Y., Lowry, O. H. & Gundersen, K. Myogenin induces a shift of enzyme activity from glycolytic to oxidative metabolism in muscles of transgenic mice. J. Cell Biol. 145, 633-642 (1999).
15. Ekmark, M., Grønevik, E., Schjerling, P. & Gundersen, K. Myogenin induces higher oxidative capacity in pre-existing mouse muscle fibres after somatic DNA transfer. J. Physiol. 548, 259-269 (2003).
16. Lin, J. et al. Transcriptional co-activator PGC-1a drives the formation of slowtwitch muscle fibres. Nature 418, 797-801 (2002).
17. Potthoff, M. J., Olson, E. N. & Bassel-Duby, R. Skeletal muscle remodeling. Curr. Opin. Rheumatol. 19, 542-549 (2007).
18. Goldspink, G. Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload. J. Anat. 194, 323-334 (1999).
19. Ciavarro, G. L. et al. The densitometric physical fractionator for counting neuronal populations: application to a mouse model of familial amyotrophic lateral sclerosis. J. Neurosci. Methods 129, 61-71 (2003).
20. Chiu, A. Y. et al. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell Neurosci. 6, 349-362 (1995).
21. Frey, D. et al. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 20, 2534-2542 (2000).
22. Fischer, L. R. et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185, 232-240 (2004).
23. Gould, T. W. et al. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 26, 8774-8786 (2006).
24. Hegedus, J., Putman, C., Tyreman, N. & Gordon, T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Physiol. 586, 2227-2251 (2008).
25. Finck, B. & Kelly, D. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116, 615-622 (2006).
26. Gundersen, K. Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise. Biol. Rev. Camb. Philos. Soc. 86, 564-600 (2011).
27. Davie, J. K. et al. Target gene selectivity of the myogenic basic helix-loop-helix transcription factor myogenin in embryonic muscle. Dev. Biol. 311, 650-664 (2007).
28. Park, K. H. & Vincent, I. Presymptomatic biochemical changes in hindlimb muscle of G93A human Cu/Zn superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1782, 462-468 (2008).
29. Da Cruz, S. et al. Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab. 15, 778-786 (2012).
30. Leick, L. et al. PGC-1{alpha} is required for AICAR-induced expression of GLUT4 and mitochondrial proteins in mouse skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 299, E456-E465 (2010).
31. Suwa, M., Nakao, H. & Kumagai, S. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J. Appl. Physiol. 95, 960-968 (2003).
32. Kennel, P. F., Finiels, F., Revah, F. & Mallet, J. Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: an electromyographic study. Neuroreport 7, 1427-1431 (1996).
33. Merlie, J. P., Mudd, J., cheng, T.-C. & Olson, E. N. Myogenin and acetylcholine receptor α gene promoters mediate transcriptional regulation in response to motor innervation. J. Biol. Chem. 269, 2461-2467 (1994).
34. Prody, C. A. & Merlie, J. P. A developmental and tissue-specific enhancer in the mouse skeletal muscle acetylcholine receptor α-subunit gene regulated by myogenic factors. J. Biol. Chem. 33, 22588-22596 (1991).
35. Gilmour, B. P., Fanger, G. R., Newton, C., Evans, S. M. & Gardener, P. D. Multiple binding sites for myogenic regulatory factors are required for expression of the acetylcholine receptor γ-subunit gene. J. Biol. Chem. 266, 19871-19874 (1991).
36. Piette, J., Bessereau, J.-L., Huchet, M. & Changeaux, J.-P. Two adjacent myoD1-binding sites regulate expression of the acetylcholine receptor α-subunit gene. Nature 345, 353-355 (1990).
37. Williams, A. H. et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326, 1549-1554 (2009).
38. Moresi, V. et al. Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 143, 35-45 (2010).
39. Legerlotz, K. & Smith, H. K. Role of MyoD in denervated, disused and exercised muscle. Muscle Nerve 38, 1087-1100 (2008).
40. Peters, D. et al. Asynchronous functional, cellular and transcriptional changes after a bout of eccentric exercise in the rat. J. Physiol. 553(Pt 3): 947-957 (2003).
41. Flynn, J. M., Meadows, E., Fiorotto, M. & Klein, W. H. Myogenin regulates exercise capacity and skeletal muscle metabolism in the adult mouse. PLoS One 5, e13535 (2010).
42. Siu, P. M., Donley, D. A., Bryner, R. W. & Alway, S. E. Myogenin and oxidative enzyme gene expression levels are elevated in rat soleus muscles after endurance training. J. Appl. Physiol. 97, 277-285 (2004).
43. Liebetanz, D., Hagermann, K., von Lewinski, F., Kahler, E. & Paulus, W. Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur. J. Neurosci. 20, 3115-3120 (2004).
44. McCrate, M. E. & Kaspar, B. K. Physical activity and neuroprotection in amyotrophic lateral sclerosis. Neuromol. Med. 10 108-117 (2008).
45. Chen, A., Montes, J. & Mitsumoto, H. The role of exercise in amyotrophic lateral sclerosis. Phys. Med. Rehabil. Clin. N. Am 19, 545-557 (2008).
46. Bello-Haas, V. et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 68, 2003-2007 (2007).
47. Wicks, P. et al. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 8, 177-179 (2007).
48. Chiò, A., Benzi, G., Dossena, M., Mutani, R. & Mora, G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128, 472-476 (2005).
49. Carreras, I. et al. Moderate exercise delays the motor performance decline in a transgenic model of ALS. Brain Res. 1313, 192-201 (2009).
50. Kirkinezos, I. G., Hernandez, D., Bradley, W. G. & Moraes, C. T. Regular exercise is beneficial to a mouse model of amyotrophic lateal sclerosis. Ann. Neurol. 53, 804-807 (2003).
51. Mahoney, D. J., Rodriguez, C., Devries, M., Yasuda, N. & Tarnopolsky, M. A. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve 29, 656-662 (2004).
52. Kaspar, B. K., Llado, J., Sherkat, N., Rothstein, J. D. & Gage, F. H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301, 839-842 (2003).
53. Tureckova, J., Wilson, E. M., Cappalonga, J. L. & Rotwein, P. Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J. Biol. Chem. 276, 39264-39270 (2001).
54. Sumitani, S., Goya, K., Testa, J. R., Kouhara, H. & Kasayama, S. Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts. Endocrinology 143, 820-828 (2002).
55. Boillée, S. et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389-1392 (2006).
56. Boillée, S., Vande Velde, C. & Cleveland, D. W. ALS: a disease of motor neurons and their non-neuronal neighbors. Neuron. 52, 39-59 (2006).
57. Clement, A. M. et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113-117 (2003).
58. Lobsinger, C. S. et al. Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc. Natl Acad. Sci. USA 106 4465-4470 (2009).
59. Lobsinger, C. S. & Cleveland, D. W. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat. Neurosci. 10, 1355-1360 (2007).
60. Yang, Y., Haecker, S. E., Su, Q. & Wilson, J. M. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum. Mol. Genet. 5, 1703-1712 (1996).